Benzinga | Apr 8, 2021 09:50AM EDT

Ovid Therapeutics Granted U.S. Patent Titled 'Methods and compositions for use treating Fragile X syndrome, Angelman syndrome'

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220210100763%22.PGNR.&OS=DN/20210100763&RS=DN/20210100763